Riskpilot← Back to searchSign inGet full accessIboloF AB
ABActiveOrg 5591303176Gustav Adolfs Torg 8 BDental practice care activities · NACE 8623Est. 20170 employees
Revenue 2025
SEK 0
EBITDA margin
—
+70% vs 2024
Equity ratio
99.9%
Financial strength
Net profit 2025
SEK 2,9M
-39% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -73K | +70% |
| Net profit | SEK 2,9M | -39% |
| Total assets | SEK 12,9M | +29% |
| Equity | SEK 12,9M | +29% |
| Employees | 0 | — |
Legal name
IboloF AB
Org number
5591303176
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
23 oktober 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska förvalta aktier och andelar samt därmed förenlig verksamhet.
Address
Gustav Adolfs Torg 8 B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | — | 0 | — | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −14 | −13 | −15 | −242 | −73 |
| Depreciation & amort. | −0 | — | −0 | — | −0 |
| EBIT | −14 | −13 | −15 | −242 | −73 |
| Net financials | −169 | 6 035 | 3 186 | 5 002 | 2 956 |
| Profit before tax | −183 | 6 022 | 3 172 | 4 760 | 2 884 |
| Tax | −0 | — | −0 | — | −0 |
| Net profit | −183 | 6 022 | 3 172 | 4 760 | 2 884 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 415 | 6 462 | 5 401 | 10 019 | 12 904 |
| Equity | 1 011 | 6 073 | 5 245 | 10 005 | 12 889 |
| Long-term debt | 4 312 | 0 | 142 | 0 | 0 |
| Short-term debt | 92 | 389 | 14 | 14 | 15 |
| Total debt | 4 404 | 389 | 156 | 14 | 15 |
EBITDA margin
-7300000.0%
This company
15.8%
Market median
-46202632% vs market
20212025
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
22.4%
This company
18.4%
Market median
+22% vs market
20212025
Net profit margin
288400000.0%
This company
8.1%
Market median
+3560493727% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DÅ | Audit | 2022 |
| Former (1) | ||
AK | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2020 | |
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 51% | 51% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tandläkare Olof Samuelsson AB
IboloF AB Board members of IboloF AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David Åke Allan Eskilsson | Audit | 0 companies |
| Anders Kenneth Larsson | Audit | 0 companies |
| Karin Beatrice af Ugglas | Deputy Board Member | 0 companies |
| Angelica Martine Ioseinov | Deputy Board Member | 0 companies |
| Ibrahim Ioseinov | Board of Directors | 0 companies |
| Olof Anders Samuelsson | Chairman | 0 companies |